Literature DB >> 23280551

Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases.

Maija-Leena Eloranta1, Gunnar V Alm, Lars Rönnblom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23280551     DOI： 10.1002/art.37821

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  20 in total

Review 1.  Self-dsDNA in the pathogenesis of systemic lupus erythematosus.

Authors:  Y Bai; Y Tong; Y Liu; H Hu
Journal:  Clin Exp Immunol       Date:  2017-09-15       Impact factor: 4.330

2.  Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.

Authors:  L Wirestam; H Enocsson; T Skogh; M L Eloranta; L Rönnblom; C Sjöwall; J Wetterö
Journal:  Clin Exp Immunol       Date:  2017-03-31       Impact factor: 4.330

Review 3.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

4.  Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.

Authors:  Ioannis Parodis; Agneta Zickert; Birgitta Sundelin; Magnus Axelsson; Jakob Gerhardsson; Elisabet Svenungsson; Vivianne Malmström; Iva Gunnarsson
Journal:  Lupus Sci Med       Date:  2015-01-22

5.  TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA.

Authors:  Christian Lood; Sabine Arve; Jeffrey Ledbetter; Keith B Elkon
Journal:  J Exp Med       Date:  2017-06-12       Impact factor: 14.307

6.  Human effector B lymphocytes express ARID3a and secrete interferon alpha.

Authors:  Julie M Ward; Michelle L Ratliff; Mikhail G Dozmorov; Graham Wiley; Joel M Guthridge; Patrick M Gaffney; Judith A James; Carol F Webb
Journal:  J Autoimmun       Date:  2016-08-10       Impact factor: 7.094

Review 7.  Cause and consequences of the activated type I interferon system in SLE.

Authors:  Maija-Leena Eloranta; Lars Rönnblom
Journal:  J Mol Med (Berl)       Date:  2016-04-20       Impact factor: 4.599

8.  Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.

Authors:  Helena Tydén; Christian Lood; Birgitta Gullstrand; Christoffer Tandrup Nielsen; Niels H H Heegaard; Robin Kahn; Andreas Jönsen; Anders A Bengtsson
Journal:  RMD Open       Date:  2017-10-25

Review 9.  The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.

Authors:  Valeria Caneparo; Santo Landolfo; Marisa Gariglio; Marco De Andrea
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

10.  Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor.

Authors:  Karin Hjorton; Niklas Hagberg; Elisabeth Israelsson; Lisa Jinton; Olof Berggren; Johanna K Sandling; Kristofer Thörn; John Mo; Maija-Leena Eloranta; Lars Rönnblom
Journal:  Arthritis Res Ther       Date:  2018-10-24       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.